Chronic Inflammation
38
6
7
16
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.5%
4 terminated out of 38 trials
80.0%
-6.5% vs benchmark
13%
5 trials in Phase 3/4
31%
5 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 16 completed trials
Clinical Trials (38)
Ultrasound-driven Stratification in CIDP
Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes
Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV
Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population
Impact of Passive Heat on Metabolic, Inflammatory and Vascular Health in Persons With Spinal Cord Injury
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation
MicroRNA Regulation of Chronic Inflammation During Aging
The Predictive Role of Preoperative Pentraxin-3 (PTX3) in Metabolic and Inflammatory Outcomes After Roux-en-Y Gastric Bypass
Pilot Study of the Human Metagenome in Metabolic Diseases
Periodic Fasting for Treatment of Long Covid in Adults: a Pilot Study
Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)
PERCI- Medium Cut Off (MCO)
Gulf War Illness Inflammation Reduction Trial
Exploring the Effects of Antihypertensive and Lipid-Lowering Drugs on Inflammatory Cytokine Levels
2021 PMT iAge® Intervention Trial by Edifice Health
Colchicine in Patients with Heart Failure with Preserved Ejection Fraction and Inflammation
30-to-90 Day Challenge: Effects of Alcohol Cessation on Health Outcomes
To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases
Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV